Loading
Latest filing published 13 Oct 2026 for Retension Pharmaceuticals, Inc., €223k. Read the official filing
No signal scores available.
Not enough history yet: 0 closed purchases, at least 2 are needed.
Eric L. Keller appears in our data through filings on Retension Pharmaceuticals, Inc. shares, published by SEC (Form 4). We count 3 filings, every one of them for a trade on 13 October 2026.
The open-market record is one-sided, with 1 purchase worth €223k and not one sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.
On 13 October 2026 came the latest disclosure, a transaction in Retension Pharmaceuticals, Inc. The most recent open-market purchase was published on 13 October 2026, 5 days ago. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations